Sai Life Sciences just opened Unit VI, a dedicated veterinary-API facility in Bidar, India.
Sai Life Sciences, a Hyderabad-based contract research, development, and manufacturing organization (CRDMO) has opened Unit VI, a dedicated veterinary-API facility in Bidar, India, adjacent to the company’s flagship API site. The company positions the site to supply animal-health sponsors and contract customers, citing rising demand for veterinary medicines and the need for dedicated manufacturing capacity that meets veterinary-specific regulatory requirements.
The new unit is configured around safety, sustainability and regulatory readiness for veterinary markets. Locating Unit VI next to the flagship Bidar campus is intended to leverage existing utilities, quality systems and experienced operations teams. Sai is targeting niche, higher-value API segments where reliable scale-up and cost control are priorities. The company says the facility will support efficient, repeatable production for global animal-health programs and provide additional sourcing depth for innovators.
The move lands amid stepped-up animal-health infrastructure investment. Merck Animal Health is putting $895 million into its De Soto, Kansas biologics campus. Of that, $860 million is allocated to manufacturing and $35 million for R&D, with commercial output expected by 2030 and more than 200 jobs projected. In addition, Zoetis recently opened its largest U.S. diagnostics reference lab at UPS Healthcare’s Labport in Louisville, a location chosen to tap air-hub logistics and faster turnaround times for veterinary diagnostics.
Beyond animal health, API capacity is expanding more broadly. AbbVie plans a $195 million API facility in North Chicago, with construction beginning fall 2025 and operations slated for 2027, an indicator of continued investment in U.S. small-molecule supply. At the policy level, FDA’s new PreCheck program is intended to streamline U.S. drug-manufacturing site development via a two-phase pathway that increases early engagement on facility readiness and quality systems—supporting ongoing onshoring efforts.
Filed Under: Veterinary medicine
